Document Detail


Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae?
MedLine Citation:
PMID:  1624115     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report the isolation of a clinical isolate of Klebsiella pneumoniae that showed resistance to ceftazidime (MIC: 8 micrograms/ml), susceptibility to aztreonam (MIC: 2 micrograms/ml) and cefotaxime (MIC: 0.015 micrograms/ml). A synergistic effect between clavulanic acid and ceftazidime or aztreonam against this strain was also observed. The strain hyperproduced SHV-1 penicillinase (990 U/g) which is encoded by a self-transferrable plasmid of at least 150 kb. That the ceftazidime-resistance phenotype could be due to hyperproduction of SHV-1 penicillinase is supported by the study of a spontaneous ceftazidime-resistant mutant in vitro obtained from an Escherichia coli strain containing plasmid p453 encoding the SHV-1. Indeed, this mutant hyperproducing SHV-1 (2200 U/g) was resistant to ceftazidime (MIC: 16 micrograms/ml) and aztreonam (MIC: 8 micrograms/ml) but susceptible to cefotaxime (MIC: 0.03 ng/ml). Clavulanic acid showed a synergistic effect when associated with ceftazidime or aztreonam. In contrast, the hyperproduction of TEM-1 (790 U/g) did not confer a ceftazidime- and aztreonam-resistant phenotype while hyperproduction of both TEM-1 and SHV-1 increased the resistance to amoxycillin/clavulanic acid and to cephalothin.
Authors:
A Petit; H Ben Yaghlane-Bouslama; L Sofer; R Labia
Related Documents :
9330665 - In vitro antimicrobial properties of azidothymidine (azt).
7018395 - Rapid distinction between micrococci and staphylococci with furazolidone agars.
9458985 - In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isola...
8988765 - Two investigational glycylcyclines, dmg-dmdot and dmg-mino. antimicrobial activity stud...
6112445 - Resistance of plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('fansidar') i...
21221945 - Multilocus sequence typing and virulence factors analysis of escherichia coli o157 stra...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  FEMS microbiology letters     Volume:  71     ISSN:  0378-1097     ISO Abbreviation:  FEMS Microbiol. Lett.     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-08-10     Completed Date:  1992-08-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7705721     Medline TA:  FEMS Microbiol Lett     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  89-94     Citation Subset:  IM    
Affiliation:
Muséum National d'Histoire Naturelle, URA 401 CNRS, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ceftazidime / pharmacology*
Clavulanic Acid
Clavulanic Acids / pharmacology
Drug Interactions
Drug Resistance, Microbial*
Drug Therapy, Combination
Enterobacteriaceae / drug effects
Klebsiella pneumoniae / drug effects*
beta-Lactamases / metabolism*
Chemical
Reg. No./Substance:
0/Clavulanic Acids; 58001-44-8/Clavulanic Acid; 78439-06-2/Ceftazidime; EC 3.5.2.-/beta-lactamase PIT-2; EC 3.5.2.6/beta-Lactamases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A non-covalent NH2-terminal pro-region aids the production of active aqualysin I (a thermophilic pro...
Next Document:  Mutation of serine residue 318 in the class C beta-lactamase of Enterobacter cloacae 908R.